Mumbai, Feb 5 (NationPress) The market for single-specialty healthcare providers in India is projected to expand to $12.3 billion by 2030, increasing from approximately $4.4 billion in 2025. This represents a remarkable 22% compound annual growth rate, outpacing the broader healthcare provider sector, according to a recent report.

Bessemer Venture Partners highlighted that specialty healthcare showcases appealing financial characteristics, including 12-18 month payback periods and sustainable EBITDA margins exceeding 20%.

The report emphasized that India’s overall healthcare provider market, valued at around $54 billion, is experiencing a significant transition from capital-heavy, multi-specialty “mega-hospitals” to purpose-built centers.

“While multi-specialty hospitals are vital for complex, multidisciplinary care, a complementary ecosystem of focused providers is rapidly evolving. These facilities are designed around repeatable protocols, concentrated clinical expertise, and asset-light expansion models,” the report noted.

These healthcare centers are described as “specialty-native” platforms, which, due to their heightened clinical focus, lead to superior outcomes and enhanced patient satisfaction in routine care segments.

“Leaner, hub-and-spoke models facilitate standardized protocols and swift replication across Tier 1 and Tier 2 cities. These platforms are exceptionally positioned to cater to high-volume, repeatable care areas such as eyecare, oncology, dental, and other condition-specific verticals,” the firm elaborated, outlining the benefits.

Founders in specialty segments have the potential to establish category dominance, as the industry currently lacks nationally recognized brands.

These emerging leaders are set to become appealing IPO candidates or acquisition targets for established healthcare conglomerates, as indicated by the report.

“As this market races toward $12 billion, we anticipate that the next generation of iconic Indian healthcare companies will emerge one specialty at a time,” remarked Nithin Kaimal, Partner at Bessemer Venture Partners, India.

The victorious platforms will be those that combine extensive clinical expertise with the ability to scale—expanding access while generating lasting value, Kaimal stated.

India accounted for 26% of the Asia-Pacific healthcare private equity (PE) deal volume in 2024, affirming its position as the largest PE market in the region by volume, another recent report indicated.

Investment activities in India have primarily focused on provider and related services, alongside biopharma and associated services.